自动注射器的全球市场（2023-2030）：按类型、应用和最终用户分類的规模、份额、成长分析和预测

全球自动注射器市场规模预计将从 2021 年的 468 亿美元成长到 2022 年的 563 亿美元，到 2030 年成长到 2,473 亿美元，预测期内年复合成长率为 17.9%。

近年来，由于慢性病盛行率增加、自我给药设备需求增加以及技术进步等多种因素，全球自动注射器市场出现了显着成长。自动注射器具有多种优点，包括易于使用、给药准确和提高患者依从性。

另一方面，自动注射器的成本可能会抑制因素市场成长，特别是在患者经济负担令人担忧的新兴国家。与传统注射器相比，自动注射器的价格较高可能会限制其在某些市场的采用。人们也担心针刺伤的风险。这种安全问题可能会限制自动注射器的采用。

本报告调查了全球自动注射器市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及各个细分市场和地区的细分。 、竞争形势、主要企业简介等。

目录

• 执行摘要
• 调查方法
• 母市场分析
  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
• 关键市场洞察
  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 重点投资分析
  • 关键成功因素
  • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
  • 法规状况
  • 波特的分析
  • Skyquest 对未来颠覆的独家见解
• 全球自动注射器市场：按类型
  • 市场概况
  • 一次性的
  • 可重复使用的
• 全球自动注射器市场：依应用分类
  • 市场概况
  • 类风湿性关节炎
  • 多发性硬化症
  • 过敏反应
  • 其他的
• 全球自动注射器市场：依最终用户分类
  • 市场概况
  • 居家医疗
  • 医院/诊所
  • 其他的
• 全球自动注射器市场：按地区
  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲
• 竞争形势
  • 前5名企业对比
  • 主要企业市场地位
  • 主要企业的招募策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率
• 主要企业简介
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Johnson & Johnson
  • Pfizer Inc.
  • Amgen Inc.
  • Mylan NV
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed AG
  • Antares Pharma, Inc.
  • Bespak Europe Ltd. (A Consort Medical Company)
  • Gerresheimer AG
  • SHL Medical AG
  • Owen Mumford Ltd.
  • Enable Injections
  • ScPharmaceuticals Inc.
  • Biogen Inc.
  • Novartis International AG
  • Merck & Co., Inc.
  • Consort Medical plc
  • Haselmeier AG

Global Auto Injector Market size was valued at USD 46.8 billion in 2021 and is poised to grow from USD 56.30 billion in 2022 to USD 247.3 billion by 2030, at a CAGR of 17.9% during the forecast period (2023-2030).

Autoinjectors are medical devices designed to deliver a specific dose of medication to patients. They are often used for the self-administration of drugs, such as epinephrine for severe allergic reactions or insulin for diabetes management. In recent years, the global auto injector market has experienced significant growth due to various factors, including the increasing prevalence of chronic diseases, rising demand for self-administration devices, and advancements in technology. Auto injectors offer several benefits, such as ease of use, accurate dosing, and improved patient compliance. Key players in the auto injector market include pharmaceutical companies, medical device manufacturers, and technology providers. These companies often compete in terms of product features, design, safety, and compatibility with different medications. Market dynamics, such as regulatory requirements, reimbursement policies, and patent protection, also influence the market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Auto-Injector Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Auto-Injector Market Segmental Analysis

The auto injectors market is segmented on the basis of type, application, end user, and region. By type, it is categorized into disposable and reusable auto injectors. Based on application, it is divided into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and others. By end user, it is categorized into home care settings and hospitals & clinics. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Auto-Injector Market Dynamics

Drivers of the Global Auto-Injector Market

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases, such as rheumatoid arthritis, multiple sclerosis, diabetes, and allergies, is a significant driver of the auto injector market. auto injectors offer a convenient and efficient way for patients to self-administer medications, empowering them to manage their conditions effectively.

There is a growing trend towards patient-centric healthcare, focusing on improving patient experience and promoting self-care. auto injectors provide patients with the ability to administer their medications at home, reducing the need for frequent hospital visits and enhancing their overall quality of life.

Restraints in the Global Auto Injector Market

High Cost of Auto Injectors

The cost of auto injector devices can be a restraint for market growth, particularly in emerging economies where affordability may be a concern for patients. The higher price of auto injectors compared to traditional syringes can limit their adoption in certain markets.

Despite the convenience they offer, auto injectors still involve needle usage, which can raise concerns about the risk of needlestick injuries. These safety concerns may limit their adoption, especially among patients who may be hesitant to self-administer injections.

Market Trends of the Global Auto Injector Key

The market is witnessing a notable trend towards self-administration of medications. Patients are increasingly seeking greater control and convenience in managing their treatment, leading to a rise in the adoption of auto injectors. These devices allow patients to self-administer medications accurately and easily, empowering them to take an active role in their healthcare journey.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Auto Injector Market by Type
  • Market Overview
  • Disposable and reusable auto injectors
• Global Auto Injector Market by Application
  • Market Overview
  • Rheumatoid arthritis
  • multiple sclerosis
  • anaphylaxis
  • and others
• Global Auto Injector Market by End-user
  • Market Overview
  • Home care settings and hospitals & clinics others
• Global Auto Injector Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Becton, Dickinson and Company (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Eli Lilly and Company (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Johnson & Johnson (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pfizer Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Amgen Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mylan N.V. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ypsomed AG (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Antares Pharma, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bespak Europe Ltd. (A Consort Medical Company), (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Gerresheimer AG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • SHL Medical AG (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Owen Mumford Ltd. (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Enable Injections (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ScPharmaceuticals Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Biogen Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Novartis International AG (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merck & Co., Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Consort Medical plc (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Haselmeier AG (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments